MARKET

GUTS

GUTS

Fractyl Health
NASDAQ
0.4486
-0.0246
-5.20%
Pre Market: 0.4648 +0.0162 +3.61% 07:45 03/30 EDT
OPEN
0.4700
PREV CLOSE
0.4732
HIGH
0.4710
LOW
0.4318
VOLUME
2.73K
TURNOVER
0
52 WEEK HIGH
3.030
52 WEEK LOW
0.3772
MARKET CAP
68.80M
P/E (TTM)
-0.1972
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GUTS last week (0323-0327)?
Weekly Report · 3h ago
Fractyl Health Earnings Call: Revita Nears Key Pivotal Test
TipRanks · 2d ago
Fractyl Health Price Target Maintained With a $8.00/Share by Canaccord Genuity
Dow Jones · 3d ago
Fractyl Health Is Maintained at Buy by Canaccord Genuity
Dow Jones · 3d ago
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merck & Company (MRK) and Abbott Laboratories (ABT)
TipRanks · 4d ago
Fractyl Health Faces Significant Compliance Risks Under Global Anti-Corruption and Sanctions Laws
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS) and Terns Pharmaceuticals (TERN)
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX), Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)
TipRanks · 5d ago
More
About GUTS
Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Webull offers Fractyl Health Inc stock information, including NASDAQ: GUTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GUTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GUTS stock methods without spending real money on the virtual paper trading platform.